Addendum to British Society for Haematology Guideline for the management of mantle cell lymphoma, 2018 (Br. J. Haematol. 2018; 182: 46-62): Risk assessment of potential CAR T candidates receiving a covalent Bruton tyrosine kinase inhibitor for relapsed/refractory disease.
作者信息
O'Reilly Maeve A, Sanderson Robin, Wilson William, Iyengar Sunil, Lambert Jonathan, McCulloch Rory, Eyre Toby A
机构信息
Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Department of Haematology, Kings college Hospital, London, UK.
出版信息
Br J Haematol. 2022 Oct;199(1):40-44. doi: 10.1111/bjh.18378. Epub 2022 Jul 27.
PMID:35894253
Abstract
摘要
Zotero 插件